Global Antithrombotic Drugs Market Will Grow by $17 Billion Over the Next 6 Years, BCC Research Forecasts
global antithrombotic/anticoagulant drugs market, valued at $29 billion in 2022, will reach $46 billion by 2028, BCC analysts project. The market’s expected CAGR between 2023 and 2028 is 7.9%
October 25, 2023
Innovative therapeutics and patient-centric solutions serve aging populations amidst increasing thrombosis prevention awareness.
Boston: The global antithrombotic/anticoagulant drugs market, valued at $29 billion in 2022, will reach $46 billion by 2028, BCC analysts project. The market’s expected CAGR between 2023 and 2028 is 7.9%. Market growth drivers include increased need for the drugs as obesity rates surge around the globe.
To keep up with the increasing demand, global pharmaceutical companies such as Bristol Myers Squibb, Johnson & Johnson, and Sanofi have led research and development and have invested heavily in low-molecular weight heparin (LMWH) anticoagulant drugs.
The report, Global Antithrombotic/Anticoagulant Drug Market, gives detailed insights into diverse categories of antithrombotic medications, including thrombin inhibitors, anticoagulants, and antiplatelets.
The report also explores:
-
Antithrombotics market growth by region: While North America holds the highest share of the market, there has been lots of activity among antithrombotic drug manufacturers in China, India, Brazil and Indonesia.
-
Market trends and forecasts: Thrombin inhibitors are expected to dominate the global antithrombotic market by the end of 2028.
-
M&A activity: The report explores the increase in mergers and acquisitions over the last 5 years and its impacts.
Thrombotic diseases, peripheral vascular diseases, valvular heart diseases, and other cardiovascular diseases are, together, the leading cause of death worldwide. Download Global Antithrombotic/Anticoagulant Drug Market to get the lowdown on therapeutic forecasts for the next five years.
For further information or to make a purchase, please get in touch with info@bccresearch.com.
Antithrombotic/Anticoagulant Drugs: Technologies and Global Markets( PHM119C )
Publish Date: Oct 2023
Data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher. For media inquiries, email press@bccresearch.com or visit www.bccresearch.com/media to request access to our library of market research.
BCC Library Membership Benefits
Unlimited Access to Market Research Reports for Academic Institutions and Corporations.
Custom Research
Tailored solutions across industries for your unique business needs.
More in Pharmaceuticals
- Global Hyaluronic Acid in Healthcare Market to Reach $10.5 Billion by 2030
- Targeted Alpha Therapies Market to Grow at 44% CAGR Globally by 2030
- Global Anti-Parkinson's Drugs Markets Projected to Reach $9.2 Billion by the End of 2030
- Rheumatoid Arthritis Therapies Market to Hit $41.1B by 2030
- Infectious Disease Therapies Market Projected to Reach $101 Billion by End of 2030
Reports from Pharmaceuticals
Recent News
- Global Patient Monitoring Market to Reach $55.8 Billion by End of 2030
- Biomarker Deals Accelerate: Strategic Alliances Reshape Life Sciences Innovation
- China’s DNA Sequencing Market to Grow at 21.5% CAGR by 2030
- Global Market for Biological and Medical Imaging Reagents Set to Surge to $40.1 Billion by 2030
- mRNA Market Forecast: Small Decline of -0.04% CAGR by 2030
